A. Skaletskaya

发表

SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies

J. Deckert, T. Chittenden, A. Plesa, 2014, Clinical Cancer Research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Development of Anilino-Maytansinoid ADCs that Efficiently Release Cytotoxic Metabolites in Cancer Cells and Induce High Levels of Bystander Killing.

E. K. Maloney, Rajeeva Singh, Y. Setiady, 2015, Bioconjugate chemistry.

Cancer Therapy : Preclinical SAR 650984 , A Novel Humanized CD 38-Targeting Antibody , Demonstrates Potent AntitumorActivity inModels ofMultiple Myeloma and Other CD 38 þ Hematologic Malignancies

C. Dumontet, P. Ferrari, V. Goldmacher, 2014 .

Cancer Therapy: Preclinical SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent AntitumorActivity inModels ofMultiple Myeloma and Other CD38þ Hematologic Malignancies

C. Dumontet, P. Ferrari, V. Goldmacher, 2014 .

The murine cytomegalovirus cell death suppressor m38.5 binds Bax and blocks Bax-mediated mitochondrial outer membrane permeabilization

C. Dufour, J. Estaquier, D. Arnoult, 2008, Apoptosis.

The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains.

D. Contopoulos-Ioannidis, N. Kedersha, W. Hayajneh, 2001, Virology.

A New Triglycyl Peptide Linker for Antibody–Drug Conjugates (ADCs) with Improved Targeted Killing of Cancer Cells

Rajeeva Singh, Y. Setiady, Rui Wu, 2016, Molecular Cancer Therapeutics.

A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.

E. Kieff, Jiawei Han, T. Chittenden, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria.

R. Youle, D. Poncet, D. Arnoult, 2004, Proceedings of the National Academy of Sciences of the United States of America.

An Anti-apoptotic Viral Protein That Recruits Bax to Mitochondria*

G. Kroemer, P. Boya, J. Martinou, 2004, Journal of Biological Chemistry.

A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation

T. Chittenden, E. Mocarski, V. Goldmacher, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses.

P. Barry, E. Mocarski, V. Goldmacher, 2003, Virology.

Synthesis and Evaluation of Camptothecin Antibody–Drug Conjugates

E. K. Maloney, Y. Setiady, T. Keating, 2019, ACS medicinal chemistry letters.

Peptide-Cleavable Self-immolative Maytansinoid Antibody–Drug Conjugates Designed To Provide Improved Bystander Killing

E. K. Maloney, Y. Setiady, Rui Wu, 2019, ACS medicinal chemistry letters.

Abstract 4564: huHER3-8, a novel humanized anti-HER3 antibody that inhibits exogeneous ligand-independent proliferation of tumor cells

T. Chittenden, Y. Setiady, C. N. Carrigan, 2011 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies

T. Chittenden, A. Plesa, M. Chiron, 2014, Clinical Cancer Research.